Dastmalchi M - Search Results

1

Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.

Barsotti S, Dastmalchi M, Notarnicola A, Leclaire V, Dani L, Gheorghe K, Ekholm L, Bottai M, Tjärnlund A, Lundberg IE. Barsotti S, et al. Among authors: dastmalchi m. Semin Arthritis Rheum. 2020 Jun;50(3):492-497. doi: 10.1016/j.semarthrit.2019.12.001. Epub 2019 Dec 28. Semin Arthritis Rheum. 2020. PMID: 32024593

2

Possible pathogenic mechanisms in inflammatory myopathies.

Lundberg IE, Dastmalchi M. Lundberg IE, et al. Among authors: dastmalchi m. Rheum Dis Clin North Am. 2002 Nov;28(4):799-822. doi: 10.1016/s0889-857x(02)00025-x. Rheum Dis Clin North Am. 2002. PMID: 12506773 Review.

3

Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis.

Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G. Fathi M, et al. Among authors: dastmalchi m. Ann Rheum Dis. 2004 Mar;63(3):297-301. doi: 10.1136/ard.2003.006122. Ann Rheum Dis. 2004. PMID: 14962966 Free PMC article.

4

Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositis.

Hassan AB, Fathi M, Dastmalchi M, Lundberg IE, Padyukov L. Hassan AB, et al. Among authors: dastmalchi m. J Autoimmun. 2006 Aug;27(1):62-8. doi: 10.1016/j.jaut.2006.06.003. Epub 2006 Aug 8. J Autoimmun. 2006. PMID: 16895750

5

Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.

Barbasso Helmers S, Dastmalchi M, Alexanderson H, Nennesmo I, Esbjörnsson M, Lindvall B, Lundberg IE. Barbasso Helmers S, et al. Among authors: dastmalchi m. Ann Rheum Dis. 2007 Oct;66(10):1276-83. doi: 10.1136/ard.2006.058644. Epub 2007 Feb 2. Ann Rheum Dis. 2007. PMID: 17277004 Free PMC article.

6

Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial.

Chung YL, Alexanderson H, Pipitone N, Morrison C, Dastmalchi M, Ståhl-Hallengren C, Richards S, Thomas EL, Hamilton G, Bell JD, Lundberg IE, Scott DL. Chung YL, et al. Among authors: dastmalchi m. Arthritis Rheum. 2007 May 15;57(4):694-702. doi: 10.1002/art.22687. Arthritis Rheum. 2007. PMID: 17471547 Free article. Clinical Trial.

7

Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis.

Alexanderson H, Dastmalchi M, Esbjörnsson-Liljedahl M, Opava CH, Lundberg IE. Alexanderson H, et al. Among authors: dastmalchi m. Arthritis Rheum. 2007 Jun 15;57(5):768-77. doi: 10.1002/art.22780. Arthritis Rheum. 2007. PMID: 17530676 Free article. Clinical Trial.

8

Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis.

Dastmalchi M, Alexanderson H, Loell I, Ståhlberg M, Borg K, Lundberg IE, Esbjörnsson M. Dastmalchi M, et al. Arthritis Rheum. 2007 Oct 15;57(7):1303-10. doi: 10.1002/art.22996. Arthritis Rheum. 2007. PMID: 17907213 Free article.

9

A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.

Dastmalchi M, Grundtman C, Alexanderson H, Mavragani CP, Einarsdottir H, Helmers SB, Elvin K, Crow MK, Nennesmo I, Lundberg IE. Dastmalchi M, et al. Ann Rheum Dis. 2008 Dec;67(12):1670-7. doi: 10.1136/ard.2007.077974. Epub 2008 Feb 13. Ann Rheum Dis. 2008. PMID: 18272672 Clinical Trial.

10

T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells.

Fasth AE, Dastmalchi M, Rahbar A, Salomonsson S, Pandya JM, Lindroos E, Nennesmo I, Malmberg KJ, Söderberg-Nauclér C, Trollmo C, Lundberg IE, Malmström V. Fasth AE, et al. Among authors: dastmalchi m. J Immunol. 2009 Oct 1;183(7):4792-9. doi: 10.4049/jimmunol.0803688. Epub 2009 Sep 14. J Immunol. 2009. PMID: 19752224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters